Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema

Completed · Phase 2 · Has a placebo group

Conditions studied: Diabetic Macular Edema

In brief

This study will evaluate the safety and efficacy of the intravitreal implant of dexamethasone with laser treatment vs. laser treatment alone in patients with diabetic macular edema.

Key facts

Study ID

NCT00464685

Run by

Allergan

People needed

253

Starts

2007-05-01

Expected to finish

2010-02-08

Last updated by the study team

2019-04-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age or older with diabetic macular edema
• Decrease in visual acuity in at least one eye as a result of macular edema (20/50 or worse)
• Visual acuity in other eye no worse than 20/200

You may not qualify if…

• Known anticipated need for ocular surgery within next 12 months
• History of glaucoma or current high eye pressure requiring more than 1 medication
• Uncontrolled systemic disease
• Known steroid-responder
• Use of systemic steroids - Use of Warfarin/Heparin

Where it is running

• Study site — Artesia, California, United States
• Study site — Victoria, British Columbia, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.